StockData
Insight Molecular Diagnostics Inc. logo

Insight Molecular Diagnostics Inc. (IMDX) stock

IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$1.78−0.08 (-4.30%)

Close on Nov 17, 2026Market cap $58.25MP/E –Yield –

Insight Molecular Diagnostics cash

Cash and short-term investments held at the end of each period.

Insight Molecular Diagnostics's cash was $17.76M at Jun 30, 2026. For fiscal 2025 it was $11.58M, up 34.1% from the year before. Over ten years it grew 3.8% a year on average. The highest annual figure on record is $32.95M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.58M+34.1%
FY2024Dec 31, 2024$8.64M-8.4%
FY2023Dec 31, 2023$9.43M-52.8%
FY2022Dec 31, 2022$19.99M-39.3%
FY2021Dec 31, 2021$32.95M+361.3%
FY2020Dec 31, 2020$7.14M-67.6%
FY2019Dec 31, 2019$22.07M+174.7%
FY2018Dec 31, 2018$8.03M+5.7%
FY2017Dec 31, 2017$7.60M-25.3%
FY2016Dec 31, 2016$10.17M+27.2%
FY2015Dec 31, 2015$8.00M+3011.3%
FY2014Dec 31, 2014$257.00K+154.5%
FY2013Dec 31, 2013$101.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$17.76M-26.9%
Q1 FY2026Mar 31, 2026$28.20M-9.1%
Q4 FY2025Dec 31, 2025$11.58M+34.1%
Q3 FY2025Sep 30, 2025$18.69M+455.8%
Q2 FY2025Jun 30, 2025$24.29M+162.4%
Q1 FY2025Mar 31, 2025$31.03M+456.3%
Q4 FY2024Dec 31, 2024$8.64M-8.4%
Q3 FY2024Sep 30, 2024$3.36M-75.6%
Q2 FY2024Jun 30, 2024$9.26M-46.7%
Q1 FY2024Mar 31, 2024$5.58M-52.7%
Q4 FY2023Dec 31, 2023$9.43M-52.8%
Q3 FY2023Sep 30, 2023$13.78M-57.0%
Q2 FY2023Jun 30, 2023$17.37M-61.3%
Q1 FY2023Mar 31, 2023$11.80M-42.2%
Q4 FY2022Dec 31, 2022$19.99M-39.3%
Q3 FY2022Sep 30, 2022$32.05M-26.0%
Q2 FY2022Jun 30, 2022$44.84M-3.5%
Q1 FY2022Mar 31, 2022$20.41M-65.3%
Q4 FY2021Dec 31, 2021$32.95M+361.3%
Q3 FY2021Sep 30, 2021$43.34M+321.1%
Q2 FY2021Jun 30, 2021$46.47M+176.7%
Q1 FY2021Mar 31, 2021$58.91M+255.4%
Q4 FY2020Dec 31, 2020$7.14M-67.6%
Q3 FY2020Sep 30, 2020$10.29M-47.1%
Q2 FY2020Jun 30, 2020$16.80M-53.1%
Q1 FY2020Mar 31, 2020$16.58M-57.8%
Q4 FY2019Dec 31, 2019$22.07M+174.7%
Q3 FY2019Sep 30, 2019$19.44M+79.7%
Q2 FY2019Jun 30, 2019$35.83M+248.0%
Q1 FY2019Mar 31, 2019$39.26M+211.3%
Q4 FY2018Dec 31, 2018$8.03M+5.7%
Q3 FY2018Sep 30, 2018$10.82M-1.8%
Q2 FY2018Jun 30, 2018$10.29M+19.1%
Q1 FY2018Mar 31, 2018$12.61M+11.1%
Q4 FY2017Dec 31, 2017$7.60M-25.3%
Q3 FY2017Sep 30, 2017$11.02M-13.0%
Q2 FY2017Jun 30, 2017$8.64M–
Q1 FY2017Mar 31, 2017$11.35M–
Q4 FY2016Dec 31, 2016$10.17M–
Q3 FY2016Sep 30, 2016$12.67M–

More Insight Molecular Diagnostics figures

See a number that looks wrong?